About GT+R 2023
Join leading biopharmaceutical and biotechnology executives, patient advocacy groups, and seasoned solution providers in discussing current trends, evolutionary innovations, strategic business models, real-world solutions, and so much more within the gene therapy industry.
Join GT+R 2023 for Three (3) days in Peabody from June 26 - 28, 2023 for a comprehensive program and inclusive gathering of gene therapy experts.
GT+R Speakers
SIMI AHMED
Senior VP, Strategic Partnerships, New York Stem Cell Foundation
COLIN DINNEY
Department Chairman, Department of Urology, UT MD Anderson Cancer Center
MARK DELVAUX
President and CEO, AlphaNet, Inc.
DANIELLE DRAYTON
CEO and Founder, REACH Market Research
PANTELI THEOCHAROUS
Global Vice President, Cell and Gene Therapy Strategy Lead, PPD
.jpg)
SHANE HEGARTY
Chief Scientific Officer & Co-Founder, AXONIS Therapeutics
PAUL HERMONAT
Chief Executive Officer, Houston Gene Therapeutics
SANJEEV LUTHER
President & CEO, Cornerstone Pharmaceuticals
Andrew B. Harmon
Strategic Consulting,
Latham Biopharma
JONI L. RUTTER
Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH)
GT+R Executive Planning Committee
.jpg)
MICHAEL FOSSEL
President and Founder
Telocyte
RAJESH B. SHUKLA
Senior Medical Director
SSI Strategy
Why Attend GT+R 2023
The time is now for action. Attendees will have the opportunity to:
-
Engage with vetted thought-leaders and seasoned industry, advocacy, academic and community-based stakeholders
-
Participate in strategically designed networking sessions and breaks
-
Identify and explore professional development opportunities
-
Identify and discuss novel, sustainable solutions to therapeutic development pain points & issues
-
Learn about innovative collaborations that are on the frontier and foster new ones
-
Participate at the first of its kind gene therapy and rare disease conference designed by a collaboration of seasoned industry experts
RESERVE YOUR SPOT TODAY
​
VENUE
Holiday Inn & Suites
Peabody, MA 01960, United States
A limited number of rooms have been blocked for GT+R attendees at the Holiday Inn & Suites,Peabody. You may confirm your lodging accommodation at the discounted rate of $240.00 USD per night upon purchasing your conference ticket(s).
Due to limited availability, lodging accommodations will be treated on a “first come first serve” basis.
For any inquiries regarding accommodation, please contact: sachin@bsc.events
Attendee Snapshot GT+R 2023
Executive decision-makers in the fields of gene therapy and rare diseases are the majority of attendees registered for GT+R 2023. The following is a list of stakeholders in which we expect the largest participation on a global scale:
-
Academia
-
Pharmaceutical/Biotechnology
-
Patient Advocacy & Community
-
Clinical Development
-
Recruitment & Retention
-
Commercial & Media Services
-
Digital Health Diagnostics
-
Genetic Counseling
-
Investors
-
Medical Affairs
-
Regulatory Affairs
-
Precision Medicine
-
Pre-Clinical/Non-Clinical
-
Specialty Pharmacy
-
Transitionary Care
-
Intellectual Property
-
Market Research & Global Access
2023 SPONSORS
